Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 02-2014 | 11-2013 | 08-2013 | 05-2013 | 02-2013 | |
| Sales | 984 | 725 | 215 | 29 | 0 |
| Cost of Goods | 749 | 495 | 174 | 22 | N/A |
| Gross Profit | 235 | 230 | 42 | 7 | N/A |
| Operating Expenses | 1,237 | 777 | 329 | 121 | 37 |
| Operating Income | -253 | -53 | -114 | -92 | -37 |
| Interest Expense | 374 | 168 | 158 | 15 | 7 |
| Other Income | -58 | -65 | -174 | 0 | -10 |
| Pre-tax Income | -685 | -285 | -446 | -107 | -54 |
| Net Income Continuous | -685 | -285 | -446 | -107 | -54 |
| Net Income Discontinuous | N/A | 96 | N/A | N/A | N/A |
| Net Income | $-685 | $-190 | $-446 | $-107 | $-54 |
| EPS Basic Total Ops | -0.01 | 0.00 | N/A | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | N/A | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | N/A | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | N/A | 0.00 | 0.00 |
| EBITDA(a) | $-233 | $-43 | $-109 | $-92 | $-37 |